Other
Chronic Periodontitis
48
Pipeline Programs↗
3
Active Trials↗
13
Companies Involved↗
Chronic Periodontitis is a moderately active landscape with 48 programs across 13 companies. The most active players are CD Pharma India Pvt. Ltd., Next Gen Pharma India Pvt. Ltd., EMD Serono. 12 therapies are approved with 12 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical8
Phase 215
Phase 312
Analysis
Trial Status
77
clinical trials
Completed64 · 83%
Unknown status10 · 13%
Active, not recruiting1 · 1%
Recruiting1 · 1%
Enrolling by invitation1 · 1%
Clinical Trials
Trial Activity
77 trials
Clinical Efficacy of 1% Metformin and Alendronate Gel in Adjunct to Fibrin in Chronic Periodontitis
Active, not recruiting·—·Phase 4·NCT06856369·120 enrolled
Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment
Completed·GGovernment Dental College and Research Institute, Bangalore·Phase 2/3·NCT02516111·120 enrolled
Locally Delivered Metformin and Aloe Vera for Treatment of Intrabody Defects in Chronic Periodontitis
Completed·GGovernment Dental College and Research Institute, Bangalore·Phase 2/3·NCT03204071·90 enrolled
1% Alendronate Gel in Treatment of Chronic Periodontitis Among Smokers
Completed·GGovernment Dental College and Research Institute, Bangalore·Phase 2·NCT02168543·46 enrolled
Flurbiprofen Versus Aloe Vera Gel in the Treatment of Chronic Periodontitis in Smoking Patients.
Completed·—·Phase 4·NCT06041178·60 enrolled
Comparison of Rosuvastatin With Atorvastatin in Chronic Periodontitis
Completed·GGovernment Dental College and Research Institute, Bangalore·Phase 2/3·NCT02600520·45 enrolled
Simvastatin Gel With Perforated Resorbable Membranes in Treatment of Intrabony Defects in Chronic Periodontitis
Completed·—·Phase 4·NCT03419429·40 enrolled
Page 1 of 6
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)